Blood Glucose Test: Fasting, Random, High & Low Results

The ADA lowers the impaired-fasting-glucose boundary to 100 mg/dL, while WHO retains 110 mg/dL. Both use 126 mg/dL for the fasting diabetes criterion. This is a classification difference, not proof that biology changes at a border or that one online chart is the only correct worldwide answer.^{See reference 1,See reference 4}

A laboratory reference interval describes results in its chosen reference population and method. A diagnostic criterion is a decision boundary linked to evidence and clinical confirmation. A treatment target is individualized for someone already being managed. Mixing those three ideas creates false certainty.^{See reference 1,See reference 2}

Glucose, A1C and two-hour OGTT identify overlapping but not identical groups because they reflect different parts of glucose biology. A normal A1C does not automatically cancel a high fasting value, and one high fasting value does not automatically overrule all other evidence.^{See reference 1}

To convert glucose from mg/dL to mmol/L, multiply by 0.0555; to convert back, multiply by about 18.018. That is why 100 mg/dL is approximately 5.6 mmol/L, 126 mg/dL is 7.0 mmol/L and 200 mg/dL is 11.1 mmol/L after clinical rounding.^{See reference 1,See reference 2}

The converter keeps the number in this browser and only changes units. It cannot determine whether the sample was fasting, confirm a diagnosis, set a pregnancy or diabetes target, or make a venous, capillary and CGM result interchangeable.^{See reference 1,See reference 2,See reference 9}

Glucose is a major fuel carried in blood. Insulin helps move it into cells, while the liver and several hormones help maintain supply between meals. A laboratory glucose test measures concentration in the collected sample; it does not directly measure insulin sensitivity, insulin production or the cause of an abnormal result.^{See reference 3}

Fasting plasma glucose reflects regulation after an overnight period without calories. Random glucose is influenced by when and what you ate, activity, illness, medicines and normal short-term variation. A1C reflects a longer period, while an OGTT deliberately tests the response to a standardized glucose load.^{See reference 1,See reference 2,See reference 3}

Because the tests sample different time windows, disagreement can be real. ADA guidance recommends attention to marked discordance and recognizes that the chosen test can change who is identified.^{See reference 1}

For a correctly collected fasting sample, persistent high glucose most often raises concern for impaired glucose regulation or diabetes. A random result may also be higher simply because it followed a meal, so the collection context comes before the cutoff.^{See reference 1,See reference 3}

Other possibilities include temporary stress from serious illness, surgery or trauma; medicines such as glucocorticoids and some antipsychotics; and less common pancreatic, adrenal or thyroid conditions. These are possibilities to evaluate, not diagnoses implied by the glucose number.^{See reference 3}

Symptoms such as increased thirst, frequent urination, blurred vision, fatigue or unexplained weight loss make prompt assessment more important. Absence of symptoms does not make a persistent abnormal fasting result irrelevant.^{See reference 1,See reference 3}

In someone using insulin or a medicine that can cause hypoglycaemia, too much medication for the available food, delayed meals, alcohol or more activity than usual can produce a clinically important low. Diabetes-care guidance treats below 70 mg/dL as an alert and below 54 mg/dL as requiring immediate action.^{See reference 3,See reference 6}

A hypoglycaemic disorder is uncommon in adults without drug-treated diabetes. The Endocrine Society recommends evaluation when Whipple’s triad is documented: compatible symptoms, a low plasma glucose at that time, and relief when glucose is raised. Symptoms alone or one asymptomatic low result does not establish the disorder.^{See reference 5}

When a true low occurs without diabetes treatment, the clinical review considers medicines, alcohol, critical illness, liver or kidney failure, hormone deficiency, malnutrition and, much less commonly, inappropriate insulin production. Delayed sample processing can also create an artificial low.^{See reference 2,See reference 3,See reference 5}

The useful goal is not to chase one laboratory number. First confirm the test context and whether an abnormal result persists. If prediabetes is confirmed, current ADA guidance supports a structured prevention program built around an evidence-based eating pattern, at least 150 minutes of moderate activity per week and, for adults with overweight or obesity at high risk, a 5–7% weight-reduction goal.^{See reference 7}

In the Diabetes Prevention Program, an intensive lifestyle program reduced diabetes incidence by 58% versus placebo over about three years among high-risk participants with elevated glucose and overweight. That is a population trial result—not a promised percentage reduction in your glucose, and not evidence that everyone should use the same diet or weight target.^{See reference 7,See reference 8}

Medicines may be appropriate for diagnosed diabetes, selected people with prediabetes, steroid-related hyperglycaemia or another specific cause. Choice and dose depend on the person. Supplements are not a substitute for confirmation, a prevention program or clinician-managed treatment, and glucose-lowering medication should never be changed from this page.^{See reference 7}